Discovery of the Extracellular Agonist Actions of Molecular Chaperones and Protein-Folding Catalysts
Publisher
Springer Netherlands
Reference88 articles.
1. Al-Abed Y, Van Patten S (2011) MIF as a disease target: ISO-1 as a proof-of-concept therapeutic. Future Med Chem 3:45–63 2. Asea A, Kraeft SK, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, Koo GC, Calderwood SK (2000) HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 6:435–442 3. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, Stevenson MA, Calderwood SK (2002) Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 277:15028–1534 4. Atanassov C, Pezennec L, d’Alayer J, Grollier G, Picard B, Fauchère JL (2002) Novel antigens of Helicobacter pylori correspond to ulcer-related antibody pattern of sera from infected patients. J Clin Microbiol 40:547–552 5. Banerjee S, Lin CF, Skinner KA, Schiffhauer LM, Peacock J, Hicks DG, Redmond EM, Morrow D, Huston A, Shayne M, Langstein HN, Miller-Graziano CL, Strickland J, O’Donoghue L, De AK (2011) Heat shock protein 27 differentiates tolerogenic macrophages that may support human breast cancer progression. Cancer Res 71:318–327
|
|